Information portal on Hereditary Angioedema (HAE)

Printed from www.hae-network.info

This document was printed on 06.Jan.2009.

| To the HAE main menu.
| HAE Range menu .
| To the search.
| Directly to contents.
| To the additional information .

Corporate websites

Pharmaceutical company websites

This list contains weblinks to corporate and drug specific sites from pharmaceutical companies developing or marketing drugs for the treatment of hereditary angioedema. It is frequently updated. Please send us your comments and suggestions by e-mail.

The following websites are operated by other parties. We do not assume any responsibility or liability for the legality, accuracy and completeness of their content.

CSL Behring, USA

Corporate website: CSL Behring


 Product for HAE treatment: Berinert® P
Nonproprietary Name: Human C1-esterase inhibitor
Description: Freeze-dried C1-esterase inhibitor concentrate for i.v. infusion
Availability: Approved in Germany, Austria, Switzerland and Hungary,
currently under review of the FDA.

CSL Behring [www.cslbehring.com]

Dyax Corp., USA

Corporate website: Dyax Corp.


 Product for HAE treatment: DX-88 (product candidate) still under clinical development
Nonproprietary Name: Kallikrein-Inhibitor DX-88    
Description: (frozen) DX-88 solution for s.c. injection
Availability: not yet available

Dyax Corporation [www.dyax.com]

Jerini AG, Germany

Corporate website: Jerini AG


Product for HAE treatment: Firazyr®
Nonproprietary Name: Bradykinin-B2-Receptor-Antagonist Icatibant (Firazyr®)  
Product Description: Prefilled syringe with Icatibant (Firazyr®) for s.c. injection
Availability: Approved in Europe

Jerini AG [www.jerini.com]

Lev Pharmaceuticals Inc., USA

Corporate website: Lev Pharmaceuticals Inc.


 Product for HAE treatment: Cynrize™
Nonproprietary Name: Human C1-esterase inhibitor
Product Description: C1-esterase inhibitor concentrate for i.v. infusion
Availability: Approved in US

Lev Pharmaceuticals [www.levpharma.com]

Pharming Group N.V., Netherlands

Corporate website: Pharming


Product for HAE treatment: Rhucin®, negative opinion by EMEA in March 2008.
Nonproprietary Name: recombinant Human C1-esterase inhibitor
Product Description: recombinant C1-esterase inhibitor concentrate for i.v. infusion
Availability: not yet available

Pharming Group N.V. [www.pharming.com]

Sanquin, Netherlands

Corporate Website: Sanquin


 Product for HAE treatment: Cetor®
Nonproprietary Name: Human C1-esterase inhibitor
Product Description: C1-esterase inhibitor concentrate for i.v. infusion
Availability: Netherlands

Sanquin [www.sanquin.nl]
Resuming information
Frequently inquired
Author: Jerini AG
Source: HAE-Network
Status: 10/08

This list is frequently updated. Please send us your comments or suggestions by e-mail.

Login

Newsletter

HAE-Network Information orphan drug
Register for the HAE newsletter

Google Map with HAE-Centres

Google Map with HAE-Centres
Find the HAE-Centres via Google Map.
The HAE Network website is a free service sponsored by Jerini AG. If you have any questions or comments please contact redaktion@hae-network.info

COPYRIGHT: All rights reserved. Unless otherwise stated, all rights to representations, illustrations and contents on this website rest solely with Jerini AG. Any publication or commercial use without authorization of Jerini AG is strictly forbidden.

NO MEDICAL ADVICE: All information, including opinions and recommendations, on this website is for educational purposes only. Such information is not intended to be a substitute for professional medical advice, diagnosis or treatment. Some parts of this website are provided for the information of health practitioners only. They are accessible via special user ID and password. THESE PARTS ARE NOT INTENDED TO BE USED BY PATIENTS.

NO WARRANTIES OR REPRESENTATIONS:All information on this website is provided without warranty of any kind, expressed or implied. Although Jerini AG makes reasonable efforts to permanently review the content of this website, it may contain errors or inaccuracies. Therefore, Jerini AG is not able to take responsibility for the accuracy, completeness, actuality or fitness for any particular purpose of the information contained herein and will not be liable for any damages or losses which might result from its use.

REFERRALS: Direct or indirect referrals to websites provided by other companies or organizations (in particular, but not limited to, through hyperlinks) do not represent any adaptation of their content. Jerini AG is not able to permanently review these websites and therefore does not take any responsibility for the legality, accuracy and completeness of the content and information on other respective websites.
Please close this window in order to go back to the previous page.
www.hae-network.info

Jerini AG / "HAE - Network" / Invalidenstrasse 130 / 10115 Berlin / Germany